Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
14.17
-0.05 (-0.35%)
At close: Aug 29, 2025, 4:00 PM
14.17
0.00 (0.00%)
After-hours: Aug 29, 2025, 4:10 PM EDT
Simulations Plus Revenue
Simulations Plus had revenue of $20.36M in the quarter ending May 31, 2025, with 9.81% growth. This brings the company's revenue in the last twelve months to $80.38M, up 20.01% year-over-year. In the fiscal year ending August 31, 2024, Simulations Plus had annual revenue of $70.01M with 17.52% growth.
Revenue (ttm)
$80.38M
Revenue Growth
+20.01%
P/S Ratio
3.55
Revenue / Employee
$325,437
Employees
247
Market Cap
285.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
| Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
| Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
| Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
| Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SLP News
- 9 hours ago - SLP SHAREHOLDERS: Simulations Plus, Inc. Investors may have been Affected by Fraud – Contact BFA Law if You Lost Money (NASDAQ:SLP) - GlobeNewsWire
- 2 days ago - Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman - GlobeNewsWire
- 2 days ago - Simulations Plus to Participate in Upcoming Investor Conferences - Business Wire
- 2 days ago - SLP INVESTOR NOTIFICATION: Simulations Plus, Inc. Investors are Urged to Contact BFA Law about the Pending Securities Fraud Investigation (NASDAQ:SLP) - GlobeNewsWire
- 4 days ago - Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman - GlobeNewsWire
- 6 days ago - SLP CLASS REMINDER: Suffer Losses on Your Simulations Plus, Inc. Investment? Contact BFA Law about the Securities Fraud Investigation (NASDAQ:SLP) - GlobeNewsWire
- 8 days ago - SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investors are Notified of the Ongoing Securities Fraud Investigation -- Contact BFA Law if You Suffered Losses (NASDAQ:SLP) - GlobeNewsWire
- 8 days ago - SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire